FUNDAMENTAL AND CLINICAL STUDIES ON TA-058 IN THE FIELD OF INTERNAL MEDICINE

Abstract

TA-058 was clinically evaluated. The results obtained were summarized as follows;
1) Antibacterial activity of TA-058 against clinical isolates of E. coli, S. marcescens and P. aeruginosa was superior to that of ABPC and AMPC.
2) Susceptibility of K. pneumoniae to TA-058 was poor.
3) Treatment with TA-058 was effective in 3 patients of 5 patients.
4) Neither adverse effect nor abnormal laboratory findings were observed.